Synta Pharmaceuticals, Inc. (SNTA) Reports Q3 Loss of $0.30
Tweet
Share
E-mailGet Alerts SNTA Hot Sheet
Price: $0.34 --0%
Financial Fact:
Interest expense, net: 41.78K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Interest expense, net: 41.78K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Synta Pharmaceuticals, Inc. (NASDAQ: SNTA) reported Q3 EPS of ($0.30), $0.01 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $1.71 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Ross Stores (ROST) Tops Q2 EPS by 72c, Beats on Revenue
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
